Shortening Duration of Antiarrhythmic Medication for SVT in Infants
Shortening Duration of Antiarrhythmic Medication for SVT in Infants
The infants diagnosed with SVT are treated with antiarrhythmic medication to prevent the recurrence of SVT. This prospective observational cohort study evaluates efficacy and safety of shortening duration of antiarrhythmic medication to four months in infants with SVT. Primary outcome is incidence of recurrent SVT in infants after 4 months of antiarrhythmic medication compared to retrospectively reviewed cohort.
Inclusion Criteria:
Exclusion Criteria: